Clinical Trial Update: A Study of Avastin (Bevacizumab) and Sequential Chemotherapy in Patients With Primary HER2 Negative Operable Breast Cancer. [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating bevacizumab (Avastin) with sequential chemotherapy in patients with primary HER2-negative operable breast cancer; the study has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Avastin (bevacizumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2014-11-10